Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets

  • Authors:
    • Sheng Zheng
    • Yan Liu
    • Yang Jiao
    • Min Wei
    • Xianlu Zeng
  • View Affiliations

  • Published online on: December 2, 2011     https://doi.org/10.3892/ol.2011.510
  • Pages: 497-502
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The interaction between platelets and tumor cells is critical for the hematogenous metastasis of tumor cells. We recently reported that fibrinogen was capable of bridging and enhancing the interaction of platelets and tumor cells under conditions of physical shear force. In the present study, we aimed to detect the effects of 8 chemically modified heparins on the binding of fibrinogen to platelets or tumor cells using flow cytometry assays, as well as the fibrinogen-bridged adhesion of platelets and tumor cells using flow chamber assays. The results showed that fibrinogen binds to platelets and tumor cells in a β3 integrin‑dependent manner and bridges the adhesion between platelets and tumor cells. Heparin and certain chemically modified heparins, including borohydride-reduced (RO)-, carboxyl-reduced (CR)- and 2-O, 3-O-desulfated (2/3ODS)-heparins, inhibited the β3 integrin-dependent adhesion of fibrinogen to platelets or tumor cells, and consequently blocked the fibrinogen-bridged indirect adhesion of platelets to tumor cells. These data indicate that chemically modified heparins should be potential inhibitors for the fibrinogen-bridged indirect adhesion of platelets and tumor cells, which provides a novel explanation of the anti-adhesion property of heparin and proposes a new anti-metastatic target for cancer treatment.
View Figures
View References

Related Articles

Journal Cover

February 2012
Volume 3 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zheng S, Liu Y, Jiao Y, Wei M and Zeng X: Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets. Oncol Lett 3: 497-502, 2012
APA
Zheng, S., Liu, Y., Jiao, Y., Wei, M., & Zeng, X. (2012). Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets. Oncology Letters, 3, 497-502. https://doi.org/10.3892/ol.2011.510
MLA
Zheng, S., Liu, Y., Jiao, Y., Wei, M., Zeng, X."Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets". Oncology Letters 3.2 (2012): 497-502.
Chicago
Zheng, S., Liu, Y., Jiao, Y., Wei, M., Zeng, X."Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets". Oncology Letters 3, no. 2 (2012): 497-502. https://doi.org/10.3892/ol.2011.510